CN104667019A - Traditional Chinese medicine composition for treating purpura caused by exogenous disease - Google Patents
Traditional Chinese medicine composition for treating purpura caused by exogenous disease Download PDFInfo
- Publication number
- CN104667019A CN104667019A CN201510124683.6A CN201510124683A CN104667019A CN 104667019 A CN104667019 A CN 104667019A CN 201510124683 A CN201510124683 A CN 201510124683A CN 104667019 A CN104667019 A CN 104667019A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 55
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 51
- 206010037549 Purpura Diseases 0.000 title claims abstract description 44
- 241001672981 Purpura Species 0.000 title claims abstract description 44
- 201000010099 disease Diseases 0.000 title claims abstract description 41
- 239000000203 mixture Substances 0.000 title claims abstract description 30
- 230000001717 pathogenic effect Effects 0.000 claims description 27
- 241000628997 Flos Species 0.000 claims description 10
- 239000009636 Huang Qi Substances 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 10
- 210000000582 semen Anatomy 0.000 claims description 10
- 229940079593 drug Drugs 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 4
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 235000016993 Agrimonia Nutrition 0.000 abstract 1
- 244000307697 Agrimonia eupatoria Species 0.000 abstract 1
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241001061264 Astragalus Species 0.000 abstract 1
- 235000010110 Astragalus glycyphyllos Nutrition 0.000 abstract 1
- 240000008537 Burchellia bubalina Species 0.000 abstract 1
- 235000004415 Burchellia bubalina Nutrition 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241000931705 Cicada Species 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 241000218378 Magnolia Species 0.000 abstract 1
- 241000123069 Ocyurus chrysurus Species 0.000 abstract 1
- 240000002948 Ophiopogon intermedius Species 0.000 abstract 1
- 244000170916 Paeonia officinalis Species 0.000 abstract 1
- 235000006484 Paeonia officinalis Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241000951473 Schizonepeta Species 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000019771 cognition Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 206010019233 Headaches Diseases 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 210000001367 artery Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 206010063659 Aversion Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000037920 primary disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 206010014080 Ecchymosis Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 206010034754 petechiae Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 208000019838 Blood disease Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019617 Henoch-Schonlein purpura Diseases 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 208000031814 IgA Vasculitis Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000008563 guizhi decoction Substances 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000012004 hematohidrosis Diseases 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 208000015446 immunoglobulin a vasculitis Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 201000009240 nasopharyngitis Diseases 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines. The invention aims at providing a traditional Chinese medicine composition for treating purpura caused by an exogenous disease according to the cognition mechanism of purpura in traditional Chinese medicines. The traditional Chinese medicine composition is prepared by combining the following active pharmaceutical ingredients in parts by weight: 6-12 parts of liquorice root, 25-35 parts of milkvetch root, 10-20 parts of dwarf lilyturf tuber, 10-20 parts of rehmannia root, 9-15 parts of divaricate saposhnikovia root, 9-15 parts of Taiwan angelica root, 9-15 parts of India madder root, 25-35 parts of lalang grass rhizome, 9-15 parts of figwort root, 25-35 parts of hairyvein agrimonia herb and bud, 9-15 parts of fineleaf schizonepeta herb, 5-15 parts of biond magnolia flower, 10-20 parts of honeycomb, 5-15 parts of cicada slough, 10-20 parts of buffalo horn, 25-35 parts of white paeony root, 10-20 parts of ephedra herb and 10-20 parts of almonds. The traditional Chinese medicine composition can obtain a satisfactory treatment effect in rational dosage by reasonable compatibility of the conventional medicines.
Description
Technical field
The invention belongs to technical field of Chinese medicines, specifically refer to a kind of Chinese medicine composition for the treatment of purpura disease caused by diseases caused by exogenous pathogenic factor.
Background technology
Purpura, also known as purpura, overflows under skin, mucosa with blood, occurs petechia ecchymosis, not fading for its Clinical symptoms of pressure, is one of common hemorrhage of children's.Normal companion's epistaxis, bleeding from the gum, very then hematemesis, have blood in stool, hematuria.Primary disease belongs to blood disorder category, and the disease such as " hemorrhagic disease with purpura ", " hematohidrosis " described in Chinese medical book, " speckle poison ", has similarity with primary disease.Primary disease comprises anaphylactoid purpura and the thrombocytopenic purpura of western medicine.
Summary of the invention
The object of the invention is according to the understanding mechanism of the traditional Chinese medical science to purpura one disease, and then a kind of Chinese medicine composition for the treatment of diseases caused by exogenous pathogenic factor this disease caused is provided.
For realizing above-mentioned technical purpose, the technical solution used in the present invention is a kind of Chinese medicine composition for the treatment of purpura disease caused by diseases caused by exogenous pathogenic factor, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Glycyrrhizae 6-12 part, Radix Astragali 25-35 part, Radix Ophiopogonis 10-20 part, Radix Rehmanniae 10-20 part, Radix Saposhnikoviae 9-15 part, Radix Angelicae Dahuricae 9-15 part, Radix Rubiae 9-15 part, Rhizoma Imperatae 25-35 part, Radix Scrophulariae 9-15 part, Herba Agrimoniae 25-35 part, Herba Schizonepetae 9-15 part, Flos Magnoliae 5-15 part, Nidus Vespae 10-20 part, Periostracum Cicadae 5-15 part, Cornu Bubali 10-20 part, Radix Paeoniae Alba 25-35 part, Herba Ephedrae 10-20 part, Semen Armeniacae Amarum 10-20 part.
The optimum weight proportioning of above-mentioned raw materials medicine is: 9 parts, Radix Glycyrrhizae, the Radix Astragali 30 parts, Radix Ophiopogonis 15 parts, Radix Rehmanniae 15 parts, Radix Saposhnikoviae 12 parts, the Radix Angelicae Dahuricae 12 parts, 12 parts, Radix Rubiae, Rhizoma Imperatae 30 parts, Radix Scrophulariae 12 parts, Herba Agrimoniae 30 parts, Herba Schizonepetae 12 parts, Flos Magnoliae 10 parts, 15 parts, Nidus Vespae, Periostracum Cicadae 10 parts, Cornu Bubali 15 parts, the Radix Paeoniae Alba 30 parts, 15 parts, Herba Ephedrae, 15 parts, Semen Armeniacae Amarum.
The instructions of taking of Chinese medicine composition provided by the present invention is: adopt the method for conventional fried Chinese medicine to get its medicine juice 300-500ml by after the mixing of the material medicine of above-mentioned weight proportion, every day takes for twice sooner or later, and every day one is secondary.
Prescription analysis: point out in " Waike Zhengzong, Orthodox Manual of External Diseases " that this disease is joined the army by pathogenic heat, muscle, space between skin and muscles point burn bright and outgoing in skin by it, speckle color is livid purple.Be more common in child and teenager.Clear Shao Xian points out, and " heat is accumulate in stomach, injures blood the moon " is its main pathogenesis.And purpura caused by diseases caused by exogenous pathogenic factor or do not disappear through disease or lose through disease and on skin existing purpura speckle.Warp, i.e. Taiyang channel, the sun is managed in row arteries and veins, defends main fur hole key, experiences's ailment said due to cold or exposure, and defend gas impaired hole key to close, and nutrient blood is dispersed for property with temperature rise, hole key closes, and nutrient blood is sent out and saturating, passes raw scorching in the bright internal organs of sun, forces nutrient blood overflow and form purpura outside arteries and veins.Therefore when controlling purpura one disease caused by diseases caused by exogenous pathogenic factor, one is its exopathogen loose, but its internal organs is warm clearly, and exopathogen goes, and defends and is so incensed that multiple then hole key opens entire degree of having, and nutrient blood not Yu Ze internal organs heat nothing is raw, purpura spontaneous recovery.Based on this understanding, in Chinese medicine composition provided by the present invention, get Herba Ephedrae, Radix Saposhnikoviae, the Radix Angelicae Dahuricae, Herba Schizonepetae, Flos Magnoliae, Periostracum Cicadae loosing the interspaces of skin and muscles, dispersing wind and cold compel heresy and go out, get Radix Astragali Gu Wei gas, Semen Armeniacae Amarum inducing QI, the Radix Paeoniae Alba, Herba Agrimoniae are held back battalion and are expelled the heat-evil, said medicine is share, and heresy goes to seek Wei Zihe, through disease from not reproducing.Get Rhizoma Imperatae, Radix Scrophulariae, Cornu Bubali, Radix Rubiae removing heat from blood, hold back the outer excessive blood adduction of effect irregular-rapid pulse of blood, the outer blood of arteries and veins goes, and purpura is from going.Because Xin Jinben is from lunar humidifying, Jin Yangming dryness of the stomach, the wet then pungent gold of domination of dryness its this gas existing, the dryness of the lung and cause the attached symptoms such as epistaxis and occur, therefore get Radix Ophiopogonis, Radix Rehmanniae lung moistening clears away heart-fire, Nidus Vespae wind-expelling pain-stopping.Above-mentioned all medicines share, and heresy is reduced phlegm and internal heat and let out, business revenue, and row is in arteries and veins, and blood is not excessive, and purpura is from going.Although this Chinese medicine composition is common drug on choice of drug, by disease dialectical Analyses accurately, conventional medicine is carried out reasonable compatibility, consideration consumption, it can obtain gratifying therapeutic effect.
Detailed description of the invention
Below in conjunction with embodiment, the present invention will be further described.
Embodiment 1
A kind of Chinese medicine composition for the treatment of purpura disease caused by diseases caused by exogenous pathogenic factor, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Glycyrrhizae 9g, Radix Astragali 30g, Radix Ophiopogonis 15g, Radix Rehmanniae 15g, Radix Saposhnikoviae 12g, Radix Angelicae Dahuricae 12g, Radix Rubiae 12g, Rhizoma Imperatae 30g, Radix Scrophulariae 12g, Herba Agrimoniae 30g, Herba Schizonepetae 12g, Flos Magnoliae 10g, Nidus Vespae 15g, Periostracum Cicadae 10g, Cornu Bubali 15g, Radix Paeoniae Alba 30g, Herba Ephedrae 15g, Semen Armeniacae Amarum 15g.
In the present embodiment, adopt the material medicine of above-mentioned weight proportion to carry out clinical trial, test as follows:
Since 2013, to have accepted caused by diseases caused by exogenous pathogenic factor purpura patient 38 example for medical treatment, the age 5-30 year between, its Symptoms is: purpura occurs that position is based on extremity and chest, and ecchymosis or petechia differ in size, skewness, does not exceed surface, the colour-fast also not pain of pressure.Wherein 26 routine patients while purpura occurs in heating, headache, the Taiyang channel diseases caused by exogenous pathogenic factor symptom such as weak, poor appetite, though other 12 examples are without diseases caused by exogenous pathogenic factor symptom, before purpura occurs, diseases caused by exogenous pathogenic factor symptom occurred, was taking diseases caused by exogenous pathogenic factor medicine existing purpura after disease disappears.Therapeutic scheme is selected to take the Chinese medicine composition provided in this embodiment, within 7 days, is a course for the treatment of.It should be noted, according to theory of Chinese medical science, pass in diseases caused by exogenous pathogenic factor, the people of yang deficiency turns to raw, now can not disperse, and purgation medicine is rushed down in application, people's then dryness-transformation heat of the excess of YANG, even if now diseases caused by exogenous pathogenic factor symptom loses, and still can with dispersing medicine.In conjunction with purpura symptom of the present invention, be evident as in exopathogen and be transferred to scorching, therefore use that to disperse medicine perfectly safe, can relievedly use.
Treatment standard
1, purpura area reduce or color thin out be effective.
2, purpura disappears, and the diseases caused by exogenous pathogenic factor transference cures such as headache, heating are for curing.
Effect is as follows:
In 38 routine patients, wherein there are 26 routine patients within 2-3 days, namely to show curative effect taking, especially there is in the patient of diseases caused by exogenous pathogenic factor symptom the diseases caused by exogenous pathogenic factor symptoms such as 21 example heating, headaches and obviously alleviate, the purpura lighter of effective patient simultaneously, the disappearance of partial portion purpura.Continue to take after this medicine amounted to for 1 course for the treatment of, 34 routine patient purpuras disappear completely, and wherein 26 examples have its diseases caused by exogenous pathogenic factor transference cure of patient of diseases caused by exogenous pathogenic factor symptom.Remain 4 routine patients to continue to take this Chinese medicine composition after 1 week, have 2 example recoveries from illness, residue 2 routine symptoms are alleviated to some extent, but do not fully recover.Known by above-mentioned clinical trial, this Chinese medicine composition is being treated on purpura one disease caused by diseases caused by exogenous pathogenic factor, its therapeutic effect exhibits excellent.
Embodiment 2
A kind of Chinese medicine composition for the treatment of purpura disease caused by diseases caused by exogenous pathogenic factor, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Glycyrrhizae 6g, Radix Astragali 25g, Radix Ophiopogonis 20g, Radix Rehmanniae 20g, Radix Saposhnikoviae 12g, Radix Angelicae Dahuricae 15g, Radix Rubiae 15g, Rhizoma Imperatae 35g, Radix Scrophulariae 12g, Herba Agrimoniae 25g, Herba Schizonepetae 15g, Flos Magnoliae 15g, Nidus Vespae 10g, Periostracum Cicadae 15g, Cornu Bubali 15g, Radix Paeoniae Alba 30g, Herba Ephedrae 20g, Semen Armeniacae Amarum 15g.
Model case
Man, 15 years old, time medical there is symmetry purpura speckle in extremity, and chest occurs on a small quantity, simultaneously headache, aversion to wind, and irritated drink is cold.
Take Chinese medicine composition that this embodiment provides after 3 days, headache, aversion to wind, irritated drink cold symptoms disappear, and purpura speckle starts to disappear simultaneously, and color is thin out, continues to take to 1 week, and purpura disappears rehabilitate completely.
Embodiment 3
A kind of Chinese medicine composition for the treatment of purpura disease caused by diseases caused by exogenous pathogenic factor, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Glycyrrhizae 12g, Radix Astragali 35g, Radix Ophiopogonis 10g, Radix Rehmanniae 10g, Radix Saposhnikoviae 9g, Radix Angelicae Dahuricae 9g, Radix Rubiae 12g, Rhizoma Imperatae 30g, Radix Scrophulariae 9g, Herba Agrimoniae 35g, Herba Schizonepetae 9g, Flos Magnoliae 5g, Nidus Vespae 20g, Periostracum Cicadae 5g, Cornu Bubali 10g, Radix Paeoniae Alba 25g, Herba Ephedrae 10g, Semen Armeniacae Amarum 10g.
Typical proportions
Female, 22 years old, there is stroke symptom, sweating, aversion to wind, rigidity pain on the head and nape before occurring in purpura, take guizhi decoction through disease transference cure after 1 day, within second day, purpura symptom appears in skin, and purpura position, based on upper limb, accounts for skin of upper extremity area 30%.
Take the Chinese medicine composition 7 days that this embodiment provides continuously, purpura speckle thoroughly disappears, and skin recovers normal, and purpura is fully recovered.
Embodiment 4
A kind of Chinese medicine composition for the treatment of purpura disease caused by diseases caused by exogenous pathogenic factor, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: 6 parts, Radix Glycyrrhizae, the Radix Astragali 35 parts, Radix Ophiopogonis 10 parts, Radix Rehmanniae 20 parts, Radix Saposhnikoviae 9 parts, the Radix Angelicae Dahuricae 15 parts, 9 parts, Radix Rubiae, Rhizoma Imperatae 35 parts, Radix Scrophulariae 9 parts, Herba Agrimoniae 35 parts, Herba Schizonepetae 9 parts, Flos Magnoliae 15 parts, 10 parts, Nidus Vespae, Periostracum Cicadae 15 parts, Cornu Bubali 10 parts, the Radix Paeoniae Alba 35 parts, 10 parts, Herba Ephedrae, 20 parts, Semen Armeniacae Amarum.
Embodiment 5
A kind of Chinese medicine composition for the treatment of purpura disease caused by diseases caused by exogenous pathogenic factor, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: 12 parts, Radix Glycyrrhizae, the Radix Astragali 25 parts, Radix Ophiopogonis 20 parts, Radix Rehmanniae 10 parts, Radix Saposhnikoviae 15 parts, the Radix Angelicae Dahuricae 9 parts, 15 parts, Radix Rubiae, Rhizoma Imperatae 25 parts, Radix Scrophulariae 15 parts, Herba Agrimoniae 25 parts, Herba Schizonepetae 15 parts, Flos Magnoliae 5 parts, 20 parts, Nidus Vespae, Periostracum Cicadae 5 parts, Cornu Bubali 20 parts, the Radix Paeoniae Alba 25 parts, 20 parts, Herba Ephedrae, 10 parts, Semen Armeniacae Amarum.
Claims (2)
1. treat the Chinese medicine composition of purpura disease caused by diseases caused by exogenous pathogenic factor for one kind, it is characterized in that, this Chinese medicine composition adopts the material medicine of following weight proportion to combine: Radix Glycyrrhizae 6-12 part, Radix Astragali 25-35 part, Radix Ophiopogonis 10-20 part, Radix Rehmanniae 10-20 part, Radix Saposhnikoviae 9-15 part, Radix Angelicae Dahuricae 9-15 part, Radix Rubiae 9-15 part, Rhizoma Imperatae 25-35 part, Radix Scrophulariae 9-15 part, Herba Agrimoniae 25-35 part, Herba Schizonepetae 9-15 part, Flos Magnoliae 5-15 part, Nidus Vespae 10-20 part, Periostracum Cicadae 5-15 part, Cornu Bubali 10-20 part, Radix Paeoniae Alba 25-35 part, Herba Ephedrae 10-20 part, Semen Armeniacae Amarum 10-20 part.
2. a kind of Chinese medicine composition for the treatment of purpura disease caused by diseases caused by exogenous pathogenic factor according to claim 1, it is characterized in that, the optimum weight proportioning of described material medicine is: 9 parts, Radix Glycyrrhizae, the Radix Astragali 30 parts, Radix Ophiopogonis 15 parts, Radix Rehmanniae 15 parts, Radix Saposhnikoviae 12 parts, the Radix Angelicae Dahuricae 12 parts, 12 parts, Radix Rubiae, Rhizoma Imperatae 30 parts, Radix Scrophulariae 12 parts, Herba Agrimoniae 30 parts, Herba Schizonepetae 12 parts, Flos Magnoliae 10 parts, 15 parts, Nidus Vespae, Periostracum Cicadae 10 parts, Cornu Bubali 15 parts, the Radix Paeoniae Alba 30 parts, 15 parts, Herba Ephedrae, 15 parts, Semen Armeniacae Amarum.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510124683.6A CN104667019B (en) | 2015-03-23 | 2015-03-23 | It is a kind of treat diseases caused by external factors caused by purpura disease Chinese medicine composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510124683.6A CN104667019B (en) | 2015-03-23 | 2015-03-23 | It is a kind of treat diseases caused by external factors caused by purpura disease Chinese medicine composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104667019A true CN104667019A (en) | 2015-06-03 |
| CN104667019B CN104667019B (en) | 2018-07-10 |
Family
ID=53302955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510124683.6A Active CN104667019B (en) | 2015-03-23 | 2015-03-23 | It is a kind of treat diseases caused by external factors caused by purpura disease Chinese medicine composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104667019B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102178763A (en) * | 2011-05-04 | 2011-09-14 | 包头中药有限责任公司 | Medicament for treating anaphylactoid purpura |
-
2015
- 2015-03-23 CN CN201510124683.6A patent/CN104667019B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102178763A (en) * | 2011-05-04 | 2011-09-14 | 包头中药有限责任公司 | Medicament for treating anaphylactoid purpura |
Non-Patent Citations (2)
| Title |
|---|
| 何平等: "刘以敏治疗小儿过敏性紫癜经验初探——附116例分析", 《中医药学刊》 * |
| 李维民等: "消斑汤治疗过敏性紫癫58 例", 《佳木斯医学院学报》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104667019B (en) | 2018-07-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102670915A (en) | Traditional Chinese medicine combination for treating hashimoto thyroiditis | |
| CN104667244A (en) | Foot bath composition for treating primary dysmenorrheal | |
| CN103816428B (en) | A kind of preparation of effective treatment diabetes | |
| CN102048893B (en) | Traditional Chinese medicine composition for treating arthromyodynia | |
| CN103223118A (en) | Traditional Chinese medicine composition for treating facial paralysis | |
| CN103948675A (en) | Traditional Chinese medicine for treating chronic rhinitis | |
| CN102085346B (en) | Traditional Chinese medicine composition for treating chronic obstructive pulmonary disease | |
| CN103385941B (en) | Chinese herbal medicine analgesic moxibustion | |
| CN102988892B (en) | Medicament for treating hysteromyoma and ovarian cysts | |
| CN103083616B (en) | Traditional Chinese medicine for treating ovarian cyst | |
| CN103006879A (en) | Traditional Chinese medicine composition for treating climacteric syndrome and preparation method thereof | |
| CN104127567A (en) | Traditional Chinese medicine composition for treating diabetic peripheral neuropathy | |
| CN101874850A (en) | Medicament for treating chronic urticaria | |
| CN106491887A (en) | A kind of neck waist health rehabilitation paste and preparation method thereof | |
| CN104667019A (en) | Traditional Chinese medicine composition for treating purpura caused by exogenous disease | |
| CN105412538A (en) | Plaster for treating hyperplasia of mammary glands | |
| CN104587385A (en) | Traditional Chinese medicine composition for treating blood stasis condensation type rosacea | |
| CN100363037C (en) | Medicine for treating rheumarthritis and traumatic injury pain and its prpen | |
| CN102258667A (en) | Chinese medicinal composition for treating arthralgia | |
| CN102626503B (en) | Chinese medicinal oral liquid for smoothing heart and enhancing intelligence | |
| CN106177292A (en) | A kind of Chinese medicine composition treating apoplexy and preparation method thereof | |
| CN102727702A (en) | Traditional Chinese medicine for treating qi stagnation type gastric diseases | |
| CN102406908B (en) | Chinese medicinal composition for treating cold with cough | |
| CN104667193B (en) | A kind of Chinese medicine composition for treating purpura disease | |
| CN102198201B (en) | Traditional Chinese medicine composition for treating deficiency-cold headache |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20180605 Address after: 528000 10 light industrial road, Chancheng District, Foshan, Guangdong, 10 Applicant after: FOSHAN SOIN PHARMACEUTICAL CO., LTD. Address before: 264300 Liming North Road, Rongcheng City, Weihai, Shandong Applicant before: Jiang Fengxia |
|
| TA01 | Transfer of patent application right | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |